Part of the ASNC delegation that went to Washington D.C. to discuss healthcare policies with members of Congress. Members of ASNC's Health Policy Committee from left: Daniel Huck, MD, MPH; David E. Winchester, MD, MS, FASNC; Suman Tandon, MD, FASNC; Vikas Veeranna, MD; Friederike Keating, MD, FASNC; and Attila Feher, MD, PhD.
The American Society of Nuclear Cardiology made its voice heard, pushing for legislation to repeal Medicare payment cuts and tie payments to inflationary increases. Prior authorization and a proposed tariff on radioisotopes were also discussed.
Clinical guidelines already recommend that these procedures be performed together when applicable. However, researchers noted, it is still not terribly common among today’s surgeons.
Tom Price, MD, an orthopedic surgeon and secretary of Health and Human Services (HHS) during the first Trump administration, says misinformation and growing distrust of healthcare workers and institutions is negatively impacting healthcare and more needs to be done to combat it.
A new surgical mitral valve from Foldax will now be commercially available in India. The valve is built using LifePolymer, a proprietary material that does not include animal tissue.
As cardiac CT continues to get used more and more, GE HealthCare has launched a new scanner designed to meet the needs of both outpatient imaging centers and larger hospitals.
Care teams have a lot to consider when choosing the right treatment for patients with severe aortic stenosis. Two cardiologists and a veteran cardiothoracic surgeon are taking part in a new webinar focused on that very topic.
Vinay Badhwar, MD, and his team perform a robotic TAVR explant and aortic valve replacement. Image courtesy of WVU Medicine.
The patient, 67, presented with a failing TAVR valve and a leaky mitral valve. She had undergone TAVR four years prior, but premature structural valve degeneration made a full replacement necessary. Surgeons ultimately removed the TAVR valve in addition to replacing her aortic and mitral valves—all with the help of advanced robotics.
Image courtesy of Andrew Brodhead/Stanford University.
The robots are capable of swimming through a patient’s vascular system and removing blood clots. “It’s unbelievable," one Stanford researcher said. "This is a sea-change technology that will drastically improve our ability to help people.”
![A majority of medical devices involved in Class I recalls were never required by the U.S. Food and Drug Administration (FDA) to undergo premarket or postmarket clinical testing, according to new research published in Annals of Internal Medicine.[1]](/sites/default/files/styles/top_stories/public/2024-09/istock-1209664264.jpg.webp?itok=gQInU1vO)
